Most Popular Articles

Association of hormone preparations with bone mineral density, osteopenia, and osteoporosis in postmenopausal women: data from National Health and Nutrition Examination Survey 1999-2018

Wang, Yiran; Sun, Chao

Menopause. 30(6):591-598, June 2023.

A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2—vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life

Gaspard, Ulysse; Taziaux, Mélanie; Jost, Maud; More

Menopause. 30(5):480-489, May 2023.

Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update

Meziou, Nadia; Scholfield, Clare; Taylor, Caroline A.; More

Menopause. 30(6):659-671, June 2023.

A dietary intervention for vasomotor symptoms of menopause: a randomized, controlled trial

Barnard, Neal D.; Kahleova, Hana; Holtz, Danielle N.; More

Menopause. 30(1):80-87, January 2023.

A survey of medical cannabis use during perimenopause and postmenopause

Dahlgren, M. Kathryn; El-Abboud, Celine; Lambros, Ashley M.; More

Menopause. 29(9):1028-1036, September 2022.

Early menopause and cardiovascular risk factors: a cross-sectional and longitudinal study

Roa-Díaz, Zayne Milena; Wehrli, Faina; Lambrinoudaki, Irene; More

Menopause. 30(6):599-606, June 2023.

Association between weekend catch-up sleep and hyperuricemia with insufficient sleep in postmenopausal Korean women: a nationwide cross-sectional study

Son, Soo Min; Park, Eun-Ju; Kwon, Ryuk Jun; More

Menopause. 30(6):607-612, June 2023.

Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA)

Santoro, Nanette; Waldbaum, Arthur; Lederman, Samuel; More

Menopause. 27(12):1350-1356, December 2020.

Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)

Simon, James A.; Anderson, Richard A.; Ballantyne, Elizabeth; More

Menopause. 30(3):239-246, March 2023.

The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN)

El Khoudary, Samar R.; Greendale, Gail; Crawford, Sybil L.; More

Menopause. 26(10):1213-1227, October 2019.

Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial

Hirschberg, Angelica Lindén; Sánchez-Rovira, Pedro; Presa-Lorite, Jesús; More

Menopause. 27(5):526-534, May 2020.

Risk factors for intrauterine device embedment in postmenopausal women: an analysis of 731 participants undergoing hysteroscopy

Jiang, Jilan; Bian, Shoufang; Li, Sen; More

Menopause. : May 09, 2023

The 2023 nonhormone therapy position statement of The North American Menopause Society

Menopause. 30(6):573-590, June 2023.

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society

Manson, JoAnn E.; Ames, Jeffrey M.; Shapiro, Marla; More

Menopause. 22(3):247-253, March 2015.

The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?

Miller, Virginia M.; Naftolin, Fredrick; Asthana, Sanjay; More

Menopause. 26(9):1071-1084, September 2019.

Practice patterns and perspectives regarding treatment for symptoms of menopause: qualitative interviews with US health care providers

DePree, Barbara; Houghton, Katherine; DiBenedetti, Dana B.; More

Menopause. 30(2):128-135, February 2023.

The menopause transition: a critical stage for cardiovascular disease risk acceleration in women

El Khoudary, Samar R.

Menopause. 30(5):556-558, May 2023.

Treatment and resource utilization for menopausal symptoms in the United States: a retrospective review of real-world evidence from US electronic health records

DePree, Barbara; Houghton, Katherine; Shiozawa, Aki; More

Menopause. 30(1):70-79, January 2023.

The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women

Moral, Eloy; Delgado, Juan L.; Carmona, Francisco; More

Menopause. 25(12):1418-1423, December 2018.

A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause

Fraser, Graeme L.; Lederman, Samuel; Waldbaum, Arthur; More

Menopause. 27(4):382-392, April 2020.

Treating where it hurts—a randomized comparative trial of vestibule estradiol for postmenopausal dyspareunia

Goetsch, Martha F.; Garg, Bharti; Lillemon, Jen; More

Menopause. 30(5):467-475, May 2023.

Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules)

Lobo, Rogerio A.; Liu, James; Stanczyk, Frank Z.; More

Menopause. 26(7):720-727, July 2019.

Diagnosis, causes, and treatment of dyspareunia in postmenopausal women

Streicher, Lauren F.

Menopause. 30(6):635-649, June 2023.

Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea–based retrospective cohort study

Yuk, Jin-Sung; Kim, Jung Min

Menopause. 30(5):497-505, May 2023.

Physical activity and exercise for hot flashes: trigger or treatment?

Witkowski, Sarah; Evard, Rose; Rickson, Jacquelyn J.; More

Menopause. 30(2):218-224, February 2023.

Natural history and malignant potential of simple ovarian cysts in postmenopausal women: a systematic review and meta-analysis

Liu, Ya-Na; Tan, Xin; Xiong, Wei; More

Menopause. 30(5):559-565, May 2023.

Endometrial safety of low-dose vaginal estrogens

Stanczyk, Frank Z.; Mandelbaum, Rachel S.; Matharu, Harpreet; More

Menopause. 30(6):650-658, June 2023.

Menopause hormone therapy and urinary symptoms: a systematic review

Christmas, Monica M.; Iyer, Shilpa; Daisy, Cassandra; More

Menopause. 30(6):672-685, June 2023.

Cytological characteristics of premalignant cervical epithelial lesions in postmenopausal women based on endocrine indices and parakeratosis

Sugisawa, Akiyuki; Toyoda, Zensei; Tanabe, Yasuka; More

Menopause. 30(2):193-200, February 2023.

The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context

Chlebowski, Rowan T.; Aragaki, Aaron K.

Menopause. 30(4):454-461, April 2023.

Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study

Arraras, Juan Ignacio; Illarramendi, Jose Juan; Manterola, Ana; More

Menopause. 30(6):613-620, June 2023.

Use of exogenous hormones in those at increased risk for breast cancer: contraceptive and menopausal hormones in gene carriers and other high-risk patients

Pederson, Holly J.; Batur, Pelin

Menopause. 30(3):341-347, March 2023.

Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

Prague, Julia K.; Roberts, Rachel E.; Comninos, Alexander N.; More

Menopause. 25(8):862-869, August 2018.

Dairy intake is not associated with improvements in bone mineral density or risk of fractures across the menopause transition: data from the Study of Women's Health Across the Nation

Wallace, Taylor C.; Jun, Shinyoung; Zou, Peishan; More

Menopause. 27(8):879-886, August 2020.

A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety

Gaspard, Ulysse; Taziaux, Mélanie; Mawet, Marie; More

Menopause. 27(8):848-857, August 2020.

Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging

Harlow, Siobán D.; Gass, Margery; Hall, Janet E.; More

Menopause. 19(4):387-395, April 2012.

Effects of topical dehydroepiandrosterone therapy in women after pelvic organ prolapse surgery

Nowakowski, Łukasz; Gałczyński, Krzysztof; Dybowski, Michał; More

Menopause. 30(6):629-634, June 2023.

Effect of laser acupuncture on pain and density of bone in osteoporotic postmenopausal women: a randomized controlled trial

Hassan, Elham S.; Maged, Ahmed Mohamed; Kotb, Amal; More

Menopause. 30(5):545-550, May 2023.

Why the product labeling for low-dose vaginal estrogen should be changed

Manson, JoAnn E.; Goldstein, Steven R.; Kagan, Risa; More

Menopause. 21(9):911-916, September 2014.

The association between hormone therapy and the risk of lung cancer in postmenopausal women: a 16-year nationwide population-based study

Wu, Chia-Chen; Chung, Chi-Hsiang; Tzeng, Nian-Sheng; More

Menopause. 30(5):521-528, May 2023.